Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Report Overview
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. These three types are members of the Orthomyxoviridae family and are structurally related.
The Seasonal Influenza Prophylactics marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for Seasonal Influenza Prophylactics (SIP).
Seasonal Influenza Prophylactics Marketed Drugs Segmentation by Molecule Type
The key molecule type for Seasonal Influenza Prophylactics marketed drug is biologic.
Seasonal Influenza Prophylactics Marketed Drugs Segmentation by Routes of Administration
The key routes of administration for Seasonal Influenza Prophylactics marketed drugs are injection and inhalational. The majority of marketed vaccines for influenza are injectable products.
Seasonal Influenza Prophylactics Marketed Drugs Analysis, by Routes of Administration, 2023 (%)
For more RoA insights into the Seasonal Influenza Prophylactics marketed drugs, download a free report sample
Seasonal Influenza Prophylactics Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for Seasonal Influenza Prophylactics pipeline drugs are oral, injection, topical, and inhalational. Of all the influenza pipeline vaccines, injection is the most common route of administration.
Seasonal Influenza Prophylactics Pipeline Drugs Analysis, by Routes of Administration, 2023 (%)
For more RoA insights into the Seasonal Influenza Prophylactics pipeline drugs, download a free report sample
Top Sponsors in the Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Market
Some of the top sponsors in the Seasonal Influenza Prophylactics marketed and pipeline drugs market are The National Institute of Allergy and Infectious Diseases, Moderna Inc, GSK plc, Stanford University, Sinovac Biotech Ltd, Seqirus Ltd, Novavax Inc, Vaxart Inc, Novartis AG, and Sanofi.
Seasonal Influenza Prophylactics Marketed Drugs Market Report Overview
Key Molecule Type | Biologic |
Key Routes of Administration | Injection and Inhalational |
Seasonal Influenza Prophylactics Pipeline Drugs Market Report Overview
Key Routes of Administration | Oral, Injection, Topical, and Inhalational |
Top Sponsors (Marketed and Pipeline Drugs) | Medigen Vaccine Biologics, CSL, Sanofi, Sinovac Biotech, BioNTech, Zhejiang Tianyuan Bio-Pharmaceutical, Wuhan Institute of Biological Products, The Institute of Vaccines and Medical Biologicals, Serum Institute of India, and Shanghai Institute of Biological Products |
Segments Covered in the Report
Seasonal Influenza Prophylactics Marketed Drugs Market Molecule Types Outlook (Number of Products)
- Biologic
Seasonal Influenza Prophylactics Marketed Drugs Market Routes of Administration Outlook (Number of Products)
- Injection
- Inhalational
Seasonal Influenza Prophylactics Pipeline Drugs Market Routes of Administration Outlook (Number of Products)
- Oral
- Injection
- Topical
- Inhalational
Scope
GlobalData’s Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Influenza Prophylactics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Influenza Prophylactics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What is the key molecule type for Seasonal Influenza Prophylactics marketed drugs?
The molecule type in the Seasonal Influenza Prophylactics marketed drugs is biologic.
-
What are the key routes of administration for Seasonal Influenza Prophylactics marketed drugs?
The key routes of administration in the Seasonal Influenza Prophylactics marketed drugs are injection and inhalational.
-
What are the key routes of administration for Seasonal Influenza Prophylactics pipeline drugs?
The key routes of administration in the Seasonal Influenza Prophylactics pipeline drugs are oral, injection, topical, and inhalational.
-
Who are the top sponsors for Seasonal Influenza Prophylactics marketed and pipeline drugs market?
The top sponsors in the Seasonal Influenza Prophylactics marketed and pipeline drugs market are Medigen Vaccine Biologics, CSL, Sanofi, Sinovac Biotech, BioNTech, Zhejiang Tianyuan Bio-Pharmaceutical, Wuhan Institute of Biological Products, The Institute of Vaccines and Medical Biologicals, Serum Institute of India, and Shanghai Institute of Biological Products.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.